RECRUITING

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition, future patients may benefit by having the ability to anticipate problems and develop methods of prevention or early intervention.

Official Title

Longitudinal Evaluation of Recipients of Hematopoietic Stem Cell Transplantation (HSCT)

Quick Facts

Study Start:1995-01
Study Completion:2099-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01629017

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participant is scheduled to receive OR has received a hematopoietic stem cell transplant (HSCT) for any condition.
  2. * Participant may have had a HSCT in another institution than Lucile Packard Children's Hospital (LPCH) yet has transferred follow-up long-term care to our institution and is being seen through the late-effects clinic from the Pediatric HSCT program.
  3. * Participant AND/OR parent/legally authorized representative is able to provide written informed consent and assent (as applicable) for participation.
  1. * Participant has relapsed from a malignant diagnosis post HSCT and is not being worked-up for a new HSCT.
  2. * Participant or patient's authorized guardian is unable to provide consent and assent

Contacts and Locations

Principal Investigator

Ami Shah
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University School of Medicine
Stanford, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Ami Shah, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1995-01
Study Completion Date2099-01

Study Record Updates

Study Start Date1995-01
Study Completion Date2099-01

Terms related to this study

Additional Relevant MeSH Terms

  • Blood and Marrow Transplant (BMT)